BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16131364)

  • 41. Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice.
    Fukushima K; Abiru N; Nagayama Y; Kobayashi M; Satoh T; Nakahara M; Kawasaki E; Yamasaki H; Ueha S; Matsushima K; Liu E; Eguchi K
    Biochem Biophys Res Commun; 2008 Mar; 367(4):719-24. PubMed ID: 18194666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A low protein diet in early life delays the onset of diabetes in the non-obese diabetic mouse.
    Chamson-Reig A; Arany EJ; Summers K; Hill DJ
    J Endocrinol; 2009 May; 201(2):231-9. PubMed ID: 19228796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional genomics in early autoimmunity.
    Melanitou E
    Ann N Y Acad Sci; 2005 Jun; 1050():64-72. PubMed ID: 16014521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperplastic islets observed in "reversed" NOD mice treated without hematopoietic cells.
    Okubo Y; Shimada A; Kanazawa Y; Shigihara T; Oikawa Y; Imai T; Miyazaki J; Itoh H
    Diabetes Res Clin Pract; 2008 Jan; 79(1):18-23. PubMed ID: 17919765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Liposome and complete Freund's adjuvant for the prevention of insulitis in non-obese diabetic mice].
    Su H; Jiang TJ; Zhou ZG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):32-4. PubMed ID: 12575229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
    Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diet with a low n-6/n-3 essential fatty acid ratio when started immediately after the onset of overt diabetes prolongs survival of type 1 diabetes model NOD mice.
    Kagohashi Y; Otani H
    Congenit Anom (Kyoto); 2010 Dec; 50(4):226-31. PubMed ID: 20727002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of genetic and maternal diabetes in the pathogenesis of visceroatrial heterotaxy in mice.
    Morishima M; Yasui H; Ando M; Nakazawa M; Takao A
    Teratology; 1996 Oct; 54(4):183-90. PubMed ID: 9122887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice.
    Choi MS; Jung UJ; Yeo J; Kim MJ; Lee MK
    Diabetes Metab Res Rev; 2008; 24(1):74-81. PubMed ID: 17932873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
    Reddy S; Chang M; Robinson E
    Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
    Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
    Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of the NK-1 receptor on islet cells and invading immune cells in the non-obese diabetic mouse.
    Persson-Sjögren S; Lejon K; Holmberg D; Forsgren S
    J Autoimmun; 2005 Jun; 24(4):269-79. PubMed ID: 15869864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological aspects of 'fulminant type 1 diabetes'.
    Nagata M; Moriyama H; Kotani R; Yasuda H; Kishi M; Kurohara M; Hara K; Yokono K
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S99-103. PubMed ID: 17478003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A morphological study on the reproductive organs as a possible cause of developmental abnormalities in diabetic NOD mice.
    Tatewaki R; Otani H; Tanaka O; Kitada J
    Histol Histopathol; 1989 Jul; 4(3):343-58. PubMed ID: 2520469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An early but intense cytokine production within the islets may be predictive for type 1 diabetes occurrence in the Bio Breeding (BB) rat.
    Papaccio G; Graziano A; d'Aquino R; De Francesco F; Puca A; Pedullà M
    J Cell Physiol; 2006 Dec; 209(3):1016-20. PubMed ID: 16972262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical study of the pancreatic basement membrane in non obese diabetic mice (NOD) with spontaneous autoimmune insulitis.
    Pavin EJ; Pinto GA; Zollner RL; Vassallo J
    J Submicrosc Cytol Pathol; 2003 Jan; 35(1):25-7. PubMed ID: 12762648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice.
    Gaskins HR; Prochazka M; Hamaguchi K; Serreze DV; Leiter EH
    J Clin Invest; 1992 Dec; 90(6):2220-7. PubMed ID: 1361492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maternal immunity to insulin does not affect diabetes risk in progeny of non obese diabetic mice.
    Koczwara K; Ziegler AG; Bonifacio E
    Clin Exp Immunol; 2004 Apr; 136(1):56-9. PubMed ID: 15030514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.